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Abstract
Objective: to investigate the associations between initial level and rate of change in grip strength (GS) and all-cause mortal-
ity in very old adults (≥85 years) over a 9.6-year follow-up.
Methods: prospective mortality data from 845 participants in the Newcastle 85+ Study were analysed for survival in rela-
tion to GS (kg, baseline and 5-year mean change) using Cox proportional hazards models.
Results: during the follow-up, 636 (75.3%) participants died. Higher baseline GS was associated with a decreased risk of
mortality in all participants [hazard ratio (HR) = 0.95, 95% confidence interval (CI): 0.93–0.98, P < 0.001], men (HR =
0.97, 95% CI: 0.95–0.99, P = 0.009) and women (HR = 0.96, 95% CI: 0.94–0.99, P = 0.007) after adjustment for health,
lifestyle and anthropometric factors. Overall GS slope had a downward trajectory and was determined in 602 participants:
451 experienced constant decline (negative slope) and 151 had increasing GS (positive slope) over time. Men and women
with a negative slope had a 16 and 33% increased risk of mortality, respectively, with every kg/year decline in GS (P ≤
0.005), and participants with a positive slope had a 31% decreased risk of mortality (P = 0.03) irrespective of baseline GS
and key covariates.
Conclusion: higher baseline GS and 5-year increase in GS were protective of mortality, whilst GS decline was associated
with an increased risk of mortality in the very old over 9.6 years, especially in women. These results add to the biological
and clinical importance of GS as a powerful predictor of long-term survival in late life.
Keywords: ageing, cohort study, mortality, risk factor, grip strength, grip strength decline, older people.
Introduction
Normative population-based studies have established a life-
span trajectory of grip strength (GS), peaking in early adult-
hood, maintained in middle life and steadily declining in late
life [1, 2]. Weak GS—values below the age and sex-specific
norms have been linked to adverse health outcomes includ-
ing mobility decline [3], disability [4] and mortality in middle
and late adulthood [5–11]. For example, findings from a glo-
bal population-based study involving urban and rural areas
from 17 countries, concluded that every 5 kg lower GS at
baseline was associated with a 16% increased risk of all-cause
and 7–17% greater risk of cause-specific mortality in 140,000
participants aged 35–70 over a 4-year follow-up [7].
GS as a measure of upper body strength correlates well
with overall muscle strength [12], and is lost much faster
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after the age of 80 [1], and more in men than women [13],
thus reflecting the increasing vulnerability to poor health
and functioning in later life. Although epidemiological evi-
dence supports GS as a simple, inexpensive screening tool
for identifying increased risk of mortality in older adults, its
predictive value is less exploited in the very old (aged 85
and over), despite the highest prevalence of muscle weak-
ness in this age group. For example, about 56% older adults
aged ≥80 in the BELFRAIL study had weak GS [14], and
over 74% of the very old in the Newcastle 85+ Study had
either low GS or slow gait speed [15]. In the present study
we investigated the discriminatory ability of initial level and
rate of change in GS over time for long-term mortality in
the very old. We postulated that for both men and women
the mean (absolute) decline in GS per year (slope) may be
more predictive of mortality than baseline muscle strength
(GS), regardless of its initial level.
Findings from the studies using the rate of change in
muscle strength and physical performance as predictors of
mortality have been mixed [13, 16–23]. For example, in the
Baltimore Longitudinal Study (BLSA) the rate of change in
GS in men aged < 60 was more important for long-term
mortality than initial level, whilst for men aged ≥60 higher
baseline GS but not slope predicted longer survival over a
40-year period [18].
To determine the importance of GS for survival in later
life, we investigated whether initial level or change in GS
were predictive of long-term mortality in the very old (aged
≥85) and whether associations differed by sex.
Methods
Study cohort
Participants belonged to the Newcastle 85+ Study, a pro-
spective cohort study of the very old living in North East
England (for details see Appendix 1, available in Age and
Ageing online). The study examined health and functioning
of a cohort born in 1921, and collected a range of bio-
logical, social, and psychological measures at baseline in
2006/07 (wave 1), 1.5 (wave 2), 3 (wave 3) and 5-year fol-
low-up (wave 4) as described [24, 25]. At baseline 845 parti-
cipants had data from multidimensional health assessments
and general practice medical records review (GPrr). Of
those, 813 (96.2%) had baseline GS measurement, followed
by 605 (71.6%), 452 (53.5%) and 294 (34.6%) at waves
2–4, respectively. The study was approved by the Newcastle
& North Tyneside Local Research Ethics Committee One.
Mortality data
Date of death was obtained through the UK Health and
Social Care Information Centre and confirmed by family
members for a few participants. Survival time (years) was
calculated from the date of baseline GS assessment to the
date of death or censoring (6 January 2016). The mean
(SD) follow-up time for the 845 participants was 5.35
(3.03) years with a maximum of 9.56 years.
GS measurements
Isotonic GS as a measure of upper body and overall muscle
strength [12] was assessed using a standardised protocol at
baseline and each follow-up using a hand-held dynamometer
(Takei hand-held Model A5401; Takei Scientific Instruments
Co., Ltd., Niigata City, Japan) as described [26]. Two measure-
ments for each hand were recorded, and the mean (M, SD)
of four measurements (in kg) calculated. Baseline GS was
used as continuous variable and categorised in sex-specific
quartiles (Q1–Q4; shown in Supplementary data, Table S1,
available in Age and Ageing online). Over 5 years 606 (71.7%)
participants had ≥2GS assessments from any wave.
GS slopes over 5 years (absolute change)
Rate of change in GS per year (slope) was calculated for all
participants with at least two consecutive GS assessments.
Of those with ‘overall’ slope determined (n = 602), 451
(74.9%) experienced negative slopes and 151 (25.1%) had
positive slopes or no change in GS. Further details are
described in Supplementary data, Appendix 1, available in
Age and Ageing online. The slopes were treated as continu-
ous, and also categorised in sex-specific tertiles (T1–T3;
shown in Supplementary data, Table S2, available in Age and
Ageing online).
Confounders
Confounders common to literature investigating mortality
risk and GS were considered for inclusion in the models
[6, 7, 10, 16, 18]. For description of confounders see
Supplementary data, Appendix 1, available in Age and Ageing
online. We included: (i) heath-related factors (self-rated
health, cognitive impairment, depressive symptoms) [25]
and multi-morbidity; (ii) lifestyle factors (current alcohol
intake and physical activity) [27] and (iii) anthropometry
[height (in cm) and fat mass (in kg)] [28]. Categorical and
continuous confounders (0.1–7% missing data) were
imputed with the referent category or sex-specific mean,
respectively, see Supplementary data, Appendix 1, available
in Age and Ageing online.
Statistics
A detailed description of statistical analysis is presented in
Supplementary data, Appendix 2, available in Age and Ageing
online.
Results
The characteristics of participants (n = 845) with complete
multidimensional health assessment and GPrr by baseline GS
sex-specific quartiles (Q1–Q4) are shown in Supplementary
data, Table S3, available in Age and Ageing online. Participants
in Q1 were more likely to have poor or fair health, multi-
morbidity, cognitive impairment and low physical activity (all
P ≤ 0.002), compared with participants in other quartiles.
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All-cause mortality and baseline GS
At the end of 9.6-year mortality follow-up, 607 (74.7%)
participants with baseline GS measurement died [261 men
and 346, P < 0.001]. Mean survival time was 5.05 years
(95% confidence interval (CI): 4.83–5.27).
Kaplan–Meier survival curves between sex-specific quar-
tiles of baseline GS showed significant differences (P <
0.001) in survival (see the Supplementary data, Appendix 3,
and Figure 1, panel A, available in Age and Ageing online).
Participants in Q4 had the longest survival (mean: 6.07
years, 95% CI: 5.66–6.48) and shortest in Q1 (mean: 3.68
years, 95% CI: 3.28–4.08). In adjusted Cox models a
reduced risk of all-cause mortality was observed with higher
baseline GS (continuous) for all participants, men and
women (Table 1). Specifically, for each kg increase in GS
we observed a 3% lower risk in men, and a 4% decreased
risk in women after adjustment for health, lifestyle factors
and anthropometry (Model 4).
All-cause mortality and GS slopes
GS slopes (overall, negative and positive) are described in
Supplementary data, Appendix 3, available in Age and Ageing
online.
Overall GS slope and mortality
At the end of the 9.6-year follow-up, 421 (69.9%) participants
with overall slope had died. Overall survival was 5.98 years
(95% CI: 5.76–6.17). Kaplan–Meier curves between sex-
specific tertiles of overall GS slope showed significant differ-
ences in survival (P = 0.001) (see Supplementary data,
Figure 1, panel B, available in Age and Ageing online).
Participants in the highest tertile (T3) had the shortest mean
survival of 5.52 years (95% CI: 5.16–5.87), and those in T2
the longest survival (6.41 years, 95% CI: 6.05–6.76) (dashed
black line). Adjusted Cox models of overall GS slope (continu-
ous) showed a 22% increased risk of all-cause mortality with
every kg/year GS change (decline) in women (P = 0.006), but
not in men after adjustment for baseline GS, health variables,
lifestyle and anthropometry (Table 2, Model 4).
Negative GS slope and mortality
Kaplan–Meier curves between sex-specific tertiles of nega-
tive GS slope showed a significant difference in survival
(P < 0.001) (see the Supplementary data, Appendix 3, and
Figure 1, panel C, available in Age and Ageing online). At the
end of the 9.6-year follow-up, 131 (29.0%) participants with
negative slopes were still alive, with overall mean survival
time 6.02 years (95% CI: 5.78–6.26). Participants in T1 had
the longest mean survival (6.51 years, 95% CI: 6.09–6.93),
whereas those in T3 had the shortest survival (5.20 years,
95% CI: 5.78–6.26). Adjusted Cox models with negative
GS slope (continuous) showed every kg/year GS decline
was associated with a 16% (P = 0.005) and 33% (P = 0.01)
increased risk in men and women, respectively, after adjust-
ment for all confounders (Table 3, Model 4).
Positive GS slope and mortality
Kaplan–Meier curves between sex-specific tertiles of posi-
tive slope showed no difference in the probability of sur-
vival (P = 0.09) (details not shown). In fully adjusted Cox
models with positive slope (continuous) (Model 4, Table S4,
Supplementary data, available in Age and Ageing online),
every kg/year increase in GS was associated with a 31%
decreased risk of mortality in all participants (P = 0.03). We
observed no significant interaction between sex and positive
GS slope, thus no sex differences in survival were explored.
The results for the sensitivity analyses are shown in
Supplementary data, Appendix 3 and Table S5, available in
Age and Ageing online.
Discussion
In this study we have shown that weaker GS at baseline
and greater decline in strength over 5 years were associated
with increased risk of mortality in very old men and women
over the 9.6 years follow-up, independently of a range of
confounding factors (multi-morbidity, cognitive impairment,
physical activity and fat mass). Men’s adjusted risk of mor-
tality was increased by 16% for every kg/year of (absolute)
GS lost, whereas women’s risk was 33% suggesting that,
although women’s overall GS slopes were less steep than
men’s [26], every kg/year that was lost reduced women’s
physiological reserve and their chances for survival.
For both sexes, initial (absolute) GS was relevant for
long-term survival irrespective of baseline physical activity
and fat mass. The predictive value of baseline GS for long-
term survival in older adults aged ≥85 has been observed
previously [16, 17]. Despite differences across the studies
reviewed, including length of follow-up and selection of
confounders, the importance of initial GS (muscle strength)
for survival over 7–10 years have been seen in the Leiden
85-plus Study (35% increased risk for those in the lowest
sex-specific tertile) [16], and in the Danish 1905-Cohort
study (lifespan was positively correlated with the GS inter-
cept in both sexes) [17]. Higher GS may indicate a greater
physiological reserve and resilience upon which survival in
old age may be exceptionally dependent [16, 17].
In contrast, the relevance of change in GS for survival
by sex (alone or in combination with initial GS) has been
less clear and warrants further investigation [13, 16–23].
Steeper GS slope may reveal immediacy of death rather
than age-related decline, and may be more accurate in iden-
tifying the risk of mortality in very old adults. To our
knowledge, only two studies have investigated the associ-
ation between GS slope and mortality in those aged ≥85
[16, 17]. Specifically, in the Leiden 85-plus Study, the high-
est tertile of the relative loss in GS over 4 years (from age
85 to 89) was independently associated with an increased
risk of all-cause mortality over 9.5 years [16]. A faster rate
of change in GS has been recognised as a predictor of mor-
tality in Swedish twins aged 79–96 [13], in older women
aged 70–79 from the Women’s Health and Aging Study II
Grip strength and all-cause mortality
3
irrespective of initial GS and key confounders [20], and in
older Mexican American men and women [each 0.1
decrease in normalised GS (GS kg/body weight kg) was
associated with a 15 and 12% increased risk of mortality,
respectively] [22].
The risk of all-cause mortality over the 9.6 years follow-
up in our study was unexpectedly higher in women than in
men for every kg/year of (absolute) GS lost, despite men
having higher baseline GS and greater annual rate of decline
[26]. There are several possible explanations for this finding.
We have previously reported that men experienced a linear
decline in GS, whereas women’s decline was non-linear—
less steep slope but a slight acceleration over 5 years [26].
This acceleration may suggest a terminal decline in physical
function, which may have influenced the association between
GS slope and mortality that we observed in women. The
Religious Order Study (participants aged 88.6 at death) reported
an accelerated decline in global motor function (including GS)
2.5 years before death [29]. When we repeated analysis
excluding women who died within 6 months after the last GS
measurement, the results changed very little (data not shown).
However, insufficient power in data may also explain the results
for mortality predicted by negative GS slope in men.
A combined effect of biological, social, psychological
and behavioural factors and differences between them in
men and women has been proposed as possible explanation
for the male–female health-survival paradox [30]. These
factors may also explain the differences in type, severity and
trajectories of common causes of death between men and
women [30]. In the present cohort, more women than men
died of cerebrovascular diseases and dementia (details not
shown), suggesting a compromised overall brain health and
weaker brain–muscle connections, which may have contrib-
uted to greater risk of mortality among women who were
losing muscle strength. Although we controlled for baseline
cognitive status in the models, cognitive trajectories and
neurological changes relevant for muscle were not captured
by the SMMSE. On the other hand, more men than women
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 1. Hazard ratios (HRs) for all-cause mortality by baseline GS (continuous) in the Newcastle 85+ Study
Model Baseline GS All participants (n1 = 813; n2 = 607) Men (n1 = 313; n2 = 261) Women (n1 = 500; n2 = 346)
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Model 1 0.99 (0.98–1.00) 0.06 0.96 (0.94–0.98) <0.001 0.92 (0.90–0.94) <0.001
Model 2 0.92 (0.90–0.94) <0.001 NA NA
Model 3 0.95 (0.93–0.98) <0.001 0.97 (0.95–0.99) 0.009 0.96 (0.94–0.99) 0.007
Model 4 0.95 (0.93–0.98) <0.001 0.97 (0.95–0.99) 0.009 0.96 (0.94–0.99) 0.007
GS, grip strength; CI, confidence intervals; Q1–Q4, quartiles of baseline GS; n1, total number of participants with baseline GS; n2, number of participants with
baseline GS who died of all causes over 9.6 years.
Model 1 is unadjusted. Model 2 is adjusted for sex and sex × baseline GS interaction term in all participants. Model 3 is adjusted for health-related factors (self-
rated health, depressive symptoms, number of chronic diseases and cognitive status) and lifestyle (physical activity and current alcohol intake). Model 4 is addition-
ally adjusted for anthropometry (fat mass and height).
The missing values for baseline self-rated health, cognitive status, physical activity, current alcohol intake and depressive symptoms were imputed as described in
Supplementary data, Appendix 1, available in Age and Ageing online. Model fit statistics are reported in Table S6 in Supplementary data, available in Age and Aging online.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2. Hazard ratios (HRs) for all-cause mortality by overall (mean) GS slope (continuous)a in the Newcastle 85+ Study
Model All participants (n1 = 602; n2 = 421) Men (n1 = 228; n2 = 179) Women (n1 = 374; n2 = 242)
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Model 1
GS slope 1.10 (1.04–1.17) 0.002 1.04 (1.04–1.23) 0.4 1.16 (1.05–1.28) 0.004
Model 2
GS slope 1.21 (1.10–1.33) <0.001 1.06 (0.98–1.15) 0.15 1.24 (1.13–1.36) <0.001
Baseline GS 0.95 (0.93–0.96) <0.001 0.96 (0.94–0.98) <0.001 0.91 (0.88–0.94) <0.001
Model 3
GS slope 1.19 (1.08–1.31) <0.001 1.03 (0.94–1.13) 0.5 1.22 (1.11–1.35) <0.001
Baseline GS 0.97 (0.95–0.99) 0.001 0.97 (0.95–0.997) 0.03 0.94 (0.92–0.98) 0.002
Model 4
GS slope 1.19 (1.08–1.31) <0.001 1.03 (0.94–1.13) 0.56 1.22 (1.11–1.35) <0.001
Baseline GS 0.96 (0.94–0.98) <0.001 0.97 (0.94–0.99) 0.01 0.95 (0.91–0.98) 0.002
GS, grip strength; CI, confidence intervals; n1, total number of participants with overall (mean) GS slope over 5 years; n2, number of participants with GS slope
who died of all causes over 9.6 years.
aOverall (mean) slope had downward trajectory, and positive numbers represent loss (decline) in GS.
Model 1 is unadjusted. Model 2 is adjusted for sex, baseline GS (continuous) and sex × GS slope interaction term (except in men and women includes only base-
line GS). Model 3 is further adjusted for health-related factors (self-rated health, depressive symptoms, number of chronic diseases and cognitive status) and life-
style (physical activity and current alcohol intake). Model 4 is additionally adjusted for anthropometry (fat mass and height).
The missing values for baseline self-rated health, cognitive status, physical activity, current alcohol intake and depressive symptoms were imputed as described in
Supplementary data, Appendix 1, available in Age and Ageing online. Model fit statistics are reported in Table S6 in Supplementary data, available in Age and Ageing online.
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died of cancers—a condition that leads to an early death,
leaving a sub-cohort of exceptionally robust and fit ‘survi-
vors’ for whom the rate of change in GS (decline) for sur-
vival may be less detrimental.
Our study has several limitations: (i) we used (mean)
absolute change in GS to model longitudinal data in survival
analysis, and early mortality of participants with only two
consecutive GS assessments (e.g. at baseline and wave 2) may
have underestimated the HR; (ii) although we adjusted for
multi-morbidity, severity and the rate of progression of indi-
vidual diseases may have affected the probability of survival;
(iii) uncontrolled confounding (e.g. type of medication and
diet); (iv) older adults with initially higher GS may have been
‘preselected’ as individuals with the highest physiological
reserve, and a selective loss to follow-up may have influenced
our results by introducing a survival effect; (v) women were
more numerous than men (500 versus 313, respectively),
which may have reduced the power to establish associations
in men and (vi) the results may not be generalised to other
populations outside England and Wales.
The strengths of our study are: (i) we have shown that
change in GS in the very old is heterogeneous—not all GS
slopes were negative, and participants who gained strength
had decreased risk of mortality; (ii) we started with a large
cohort of very old people, and prospectively evaluated GS
over 5 years in relation to long-term survival in men and
women and (iii) we included a range of confounders com-
monly reported in the mortality literature.
To conclude, we confirmed the predictive value of base-
line GS for long-term survival (~10 years) in both men and
women aged 85 years, adding to importance of muscle
strength for longevity in very late life. Additionally, we
reported decline in GS (negative slope) as being predictive
of mortality in men and women independently of initial
strength and other key covariates. To confirm the biological
and clinical importance of GS as a predictor of long-term
survival in very old adults, the results need to be explored
further in future prospective cohort studies that include a
greater number of older men.
Key points
• We examined the association between initial level and 5-
year rate of change in GS and mortality in the very old
(aged ≥85).
• Every kg higher baseline GS was associated with a 3 and
4% reduced risk of 10-year mortality in men and women,
respectively.
• Every kg/year GS loss was associated a 16 (men) and
33% (women) increased risk of mortality.
• Five-year increase in GS was protective of mortality.
Supplementary data
Supplementary data mentioned in the text is available to
subscribers in Age and Ageing online.
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Table 3. Hazard ratios (HRs) for all-cause mortality by (mean) negative GS slope (continuous)a in the Newcastle 85+ Study
Model All participants (n1 = 451; n2 = 320) Men (n1 = 183; n2 = 144) Women (n1 = 268; n2 = 176)
HR (95% CI) P value HR (95% CI) P value HR (95% CI) P value
Model 1
GS slope 1.19 (1.12–1.27) <0.001 1.13 (1.04–1.23) 0.003 1.29 (1.16–1.44) <0.001
Model 2
GS slope 1.31 (1.18–1.45) <0.001 1.14 (1.05–1.23) 0.002 1.30 (1.18–1.44) <0.001
Baseline GS 0.94 (0.92–0.96) <0.001 0.95 (0.93–0.98) <0.001 0.92 (0.88–0.96) <0.001
Model 3
GS slope 1.31 (1.17–1.46) <0.001 1.14 (1.03–1.27) 0.01 1.32 (1.17–1.49) <0.001
Baseline GS 0.96 (0.94–0.98) <0.001 0.96 (0.93–0.99) 0.006 0.95 (0.91–0.99) 0.01
Model 4
GS slope 1.31 (1.17–1.46) <0.001 1.16 (1.05–1.29) 0.005 1.33 (1.18–1.50) <0.001
Baseline GS 0.95 (0.93–0.98) <0.001 0.96 (0.93–0.99) 0.006 0.94 (0.90–0.98) 0.004
GS, grip strength; CI, confidence intervals; n1, total number of participants with (mean) negative GS slope (GS decline) over 5 years; n2, number of participants
with GS decline who died of all causes over 9.6 years.
aNegative slope (GS decline) was represented by positive numbers. Greater values represent greater loss in GS.
Model 1 is unadjusted. Model 2 is adjusted for sex, baseline GS (continuous) and sex × GS slope interaction term (except in men and women includes only base-
line GS). Model 3 is additionally adjusted for health-related factors (self-rated health, depressive symptoms, number of chronic diseases and cognitive status) and
lifestyle (physical activity and current alcohol intake). Model 4 is further adjusted for anthropometry (fat mass and height).
The missing values for baseline self-rated health, cognitive status, physical activity, current alcohol intake and depressive symptoms were imputed as described in
Supplementary data, Appendix 1, available in Age and Ageing online.
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